Clarity Medical Group Holding Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Chris Hui

Geschäftsführender

HK$2.2m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	96.6%
Amtszeit als Geschäftsführer	2.1yrs
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	3.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	5.3yrs

Jüngste Management Updates

Recent updates

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Mar 21

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Dec 26

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Aug 16

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Chris Hui im Vergleich zu den Einnahmen von Clarity Medical Group Holding verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	-HK$76m
Dec 31 2023	n/a	n/a	-HK$53m
Sep 30 2023	n/a	n/a	-HK$31m
Jun 30 2023	n/a	n/a	-HK$17m
Mar 31 2023	HK$2m	HK$2m	-HK$3m
Dec 31 2022	n/a	n/a	HK$4m
Sep 30 2022	n/a	n/a	HK$11m
Jun 30 2022	n/a	n/a	HK$12m
Mar 31 2022	HK$27k	n/a	HK$13m

Vergütung im Vergleich zum Markt: ChrisDie Gesamtvergütung ($USD278.64K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD231.79K).

Entschädigung vs. Einkommen: ChrisDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Chris Hui (56 yo)

2.1yrs

Amtszeit

HK$2,177,000

Vergütung

Mr. Yung Hui, also known as Chris, served as External Supervisor at China Bohai Bank Co., Ltd. since December 16, 2019. He is CEO & Executive Director of Clarity Medical Group Holding Limited from June 30,...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Yung Hui	CEO & Executive Director	2.1yrs	HK$2.18m	keine Daten
Kin Ho	Financial Controller	9.3yrs	keine Daten	keine Daten
Tsz Hong Lo	Executive Director	5.3yrs	HK$663.00k	0.35% HK$ 925.0k
Wai Ip Tse	Executive Director	2.1yrs	HK$306.00k	14.8% HK$ 39.1m
Po Yu Chan	Company Secretary	no data	keine Daten	keine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

50.5yo

Durchschnittliches Alter

Erfahrenes Management: 1406Das Führungsteam des Unternehmens gilt als erfahren (3.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Yung Hui	CEO & Executive Director	2.1yrs	HK$2.18m	keine Daten
Tsz Hong Lo	Executive Director	5.3yrs	HK$663.00k	0.35% HK$ 925.0k
Wai Ip Tse	Executive Director	2.1yrs	HK$306.00k	14.8% HK$ 39.1m
Wai Hung Ma	Independent Non-Executive Director	3.2yrs	HK$240.00k	keine Daten
Roy Ng	Non-Executive Director	5.3yrs	HK$240.00k	0.85% HK$ 2.2m
Ting Yuk Wu	Non-Executive Chairman	5.3yrs	HK$480.00k	0.71% HK$ 1.9m
Wei Zhao	Non-Executive Director	5.3yrs	HK$240.00k	keine Daten
Hankin Li	Independent Non-Executive Director	5.3yrs	HK$240.00k	keine Daten
Jessica Cheng	Independent Non-Executive Director	less than a year	keine Daten	keine Daten

5.3yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrener Vorstand: 1406Die Vorstandsmitglieder gelten als erfahren (5.2 Jahre durchschnittliche Amtszeit).

Clarity Medical Group Holding Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Recent updates

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

New major risk - Revenue size

New minor risk - Share price stability

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Clarity Medical Group Holding Limited, Annual General Meeting, Sep 20, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

New minor risk - Financial data availability

Clarity Medical Group Holding Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Year Ended 31 March 2023

Executive Director recently bought HK$589k worth of stock

Investor sentiment improves as stock rises 16%

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Non-Executive Director exercised options to buy HK$4.5m worth of stock.

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Now 24% undervalued after recent price drop

Less than half of directors are independent

Clarity Medical Group Holding Limited to Report First Half, 2023 Results on Nov 28, 2022

Clarity Medical Group Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2022

Investor sentiment improved over the past week

Executive Director recently bought HK$110k worth of stock

Investor sentiment deteriorated over the past week

Executive Director recently bought HK$59k worth of stock

Executive Director recently bought HK$735k worth of stock

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Executive Director recently bought HK$166k worth of stock

Clarity Medical Group Holding Limited Announces Executive Changes

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 26, 2022

Clarity Medical Group Holding Limited to Report Fiscal Year 2022 Results on Jun 28, 2022

Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022

Executive Director recently sold HK$1.3m worth of stock

Less than half of directors are independent

Executive Director recently sold HK$378k worth of stock

Investor sentiment improved over the past week

Executive Director recently sold HK$58k worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought HK$7.6m worth of stock

Clarity Medical Group Holding Limited has completed an IPO in the amount of HKD 217.6 million.

Less than half of directors are independent

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter